CEO Bryan Hanson said the company's funnel for Rosa placements is the strongest it's ever been and the surgical robotics system is expected to be a key growth driver for ZB in 2020.

The New Brunswick, NJ-based company and its Ethicon subsidiary were sued by the state of California for allegedly conducting deceptive marketing practices for pelvic mesh products.

Back in 2013, analysts balked at the price Stryker paid to acquire Mako, but the company just reported its strongest robot quarter since the launch of its ever popular surgical robot.

The surgical robotics pioneer is seeing some impact from increasing noise level in the market, but CEO Gary Guthart says the company is "well-positioned to have a conversation about that" as customers listen to competing pitches.

We expect to see big things from these 20 companies in the year ahead.

Augmedics has received a nod from FDA for the xvision Spine system. The Chicago, IL-based company's technology is an augmented reality guidance system to be used in spine surgery.

The New Brunswick, N.J.-based company said it would acquire the remaining stake in Verb Surgical, a joint venture the company has with Verily.

Zimmer Biomet, MD+DI's 2019 Medtech Company of the Year, stood out from the rest because of its impressive turnaround efforts.

Fresh on the heels of its FDA clearance, Xact Robotics raised $36 million to support the U.S. launch and continued development of its hands-free robot.

Based on positive study results, Medtronic is seeking a PMA supplement from FDA to expand the use of Micra to patients with AV block and normal sinus rhythm. Micra, which is touted as the world's smallest pacemaker, was approved by FDA in 2016 for...